Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Goodwill & Intangibles (2019 - 2025)

AVITA Medical filings provide 6 years of Goodwill & Intangibles readings, the most recent being $5.6 million for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 2.17% to $5.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.6 million, a 2.17% decrease, with the full-year FY2025 number at $5.6 million, down 2.17% from a year prior.
  • Goodwill & Intangibles hit $5.6 million in Q4 2025 for AVITA Medical, down from $5.8 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $5.8 million in Q3 2025 to a low of $443000.0 in Q4 2021.
  • Median Goodwill & Intangibles over the past 5 years was $676500.0 (2021), compared with a mean of $1.9 million.
  • Biggest five-year swings in Goodwill & Intangibles: crashed 37.04% in 2023 and later soared 1084.8% in 2024.
  • AVITA Medical's Goodwill & Intangibles stood at $443000.0 in 2021, then grew by 4.97% to $465000.0 in 2022, then grew by 4.73% to $487000.0 in 2023, then soared by 1084.8% to $5.8 million in 2024, then dropped by 2.17% to $5.6 million in 2025.
  • The last three reported values for Goodwill & Intangibles were $5.6 million (Q4 2025), $5.8 million (Q3 2025), and $5.8 million (Q2 2025) per Business Quant data.